A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Lispro Mix 25 to Humalog® Mix 25 in Healthy Subjects

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 12, 2017

Primary Completion Date

July 13, 2017

Study Completion Date

July 13, 2017

Conditions

Clamp Study

Interventions

DRUG

Insulin Lispro Mix 25

insulin lispro biphasic in doses 0.4 ME/kg

DRUG

Humalog® Mix 25

insulin lispro biphasic in doses 0.4 ME/kg

Trial Locations (2)

"LLL BioEq", Saint Petersburg

"FSBIENDOCRINOLOGY NMRC Ministry of Health of the Russian Federation", Moscow